| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.001 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |